Characterizing Risk Factors and Outcomes in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer Who Do Not Complete, or Who Experience Progression During/Within 42 Days of, Concurrent Chemoradiotherapy: The POSITION Study
- DOI
- 10.1016/j.cllc.2026.01.005
- Published
- 2026-04
- Container
- Clinical Lung Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.cllc.2026.01.005,
title = {Characterizing Risk Factors and Outcomes in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer Who Do Not Complete, or Who Experience Progression During/Within 42 Days of, Concurrent Chemoradiotherapy: The POSITION Study},
author = {Giannis Mountzios and Julius K. Weng and Eleni Zairi and Kristin Hsieh and Pratibha Chander and William Dunlop and Yao Qiao and Alice Wang and Adam Januszewski},
year = {2026},
journal = {Clinical Lung Cancer},
doi = {10.1016/j.cllc.2026.01.005},
url = {https://doi.org/10.1016/j.cllc.2026.01.005}
}RIS
TY - JOUR TI - Characterizing Risk Factors and Outcomes in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer Who Do Not Complete, or Who Experience Progression During/Within 42 Days of, Concurrent Chemoradiotherapy: The POSITION Study AU - Giannis Mountzios AU - Julius K. Weng AU - Eleni Zairi AU - Kristin Hsieh AU - Pratibha Chander AU - William Dunlop AU - Yao Qiao AU - Alice Wang AU - Adam Januszewski PY - 2026 JO - Clinical Lung Cancer DO - 10.1016/j.cllc.2026.01.005 UR - https://doi.org/10.1016/j.cllc.2026.01.005 ER -
APA
Mountzios, G., Weng, J. K., Zairi, E., Hsieh, K., Chander, P., Dunlop, W., Qiao, Y., Wang, A., & Januszewski, A. (2026). Characterizing Risk Factors and Outcomes in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer Who Do Not Complete, or Who Experience Progression During/Within 42 Days of, Concurrent Chemoradiotherapy: The POSITION Study. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2026.01.005
Source records
- crossref · retrieved 2026-09-25T02:58:12.261Z